Table 6.
COX proportional hazard regression model test (enter method) for OS
| B | SE | Wald | p-Value | Exp(B) | 95% CI for Exp(B) | ||
| Lower | Upper | ||||||
| Age | 0.039 | 0.032 | 1.437 | 0.231 | 1.040 | 0.976 | 1.108 |
| Tumour size | 0.103 | 0.029 | 12.729 | 0.000 | 1.109 | 1.048 | 1.173 |
| Number of positive LNs | 0.326 | 0.140 | 5.431 | 0.020 | 1.385 | 1.053 | 1.821 |
| Histological grade | 0.167 | 0.885 | 0.036 | 0.851 | 1.181 | 0.209 | 6.694 |
| LVI | −0.417 | 0.862 | 0.234 | 0.628 | 0.659 | 0.122 | 3.570 |
| HR | −0.779 | 0.603 | 1.670 | 0.196 | 0.459 | 0.141 | 1.495 |
| HER2 | 1.504 | 0.504 | 8.917 | 0.003 | 4.500 | 1.677 | 12.079 |
| Ki67 | −0.504 | 3.053 | 0.027 | 0.869 | 0.604 | 0.002 | 239.819 |
| Chemotherapy | −1.964 | 0.882 | 4.961 | 0.026 | 0.140 | 0.025 | 0.790 |
HER2, human epidermal growth factor 2; HR, hormone receptor; LN, lymph node; LVI, lymphovascualar invasion; OS, overall survival.